147 results on '"Andrews, Mark L."'
Search Results
2. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial—Cardiac Resynchronization Therapy (MADIT-CRT)
3. Participation of Calmodulin in Immunoglobulin Capping
4. Control of Erythrocyte Shape by Calmodulin
5. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy
6. Relations Among Renal Function, Risk of Sudden Cardiac Death, and Benefit of the Implanted Cardiac Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
7. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
8. Risk Factors for Recurrent Heart Failure Events in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)
9. Phenotypic Variability in Caucasian and Japanese Patients with Matched LQT1 Mutations
10. Mechanisms of Ventricular Fibrillation Initiation in MADIT II Patients with Implantable Cardioverter Defibrillators
11. Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT-II Substudy
12. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II
13. Cigarette Smoking and the Risk of Supraventricular and Ventricular Tachyarrhythmias in High-Risk Cardiac Patients with Implantable Cardioverter Defibrillators
14. Differences in Outcomes Between Patients Treated with Single- versus Dual-Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II
15. Temporal aspects of improved survival with the implanted defibrillator (MADIT-II)
16. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
17. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with the long QT syndrome
18. Asthma and the risk of cardiac events in the long QT syndrome
19. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome
20. Clinical Aspects of Type 3 Long-QT Syndrome:An International Multicenter Study
21. Clinical Aspects of Type 3 Long-QT Syndrome
22. Beta-blocker Efficacy in Long-QT Syndrome Patients with Mutations in the Pore and Nonpore Regions of the hERG Potassium-channel Gene
23. Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT Intervals
24. Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT Intervals
25. Genotype-Phenotype Aspects of Type 2 Long QT Syndrome
26. Long-QT Syndrome After Age 40
27. Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome
28. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II
29. Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
30. Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene
31. Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction
32. Long QT Syndrome and Pregnancy
33. Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome
34. Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II
35. The Cost Effectiveness of Implantable Cardioverter-Defibrillators
36. Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
37. Reduction in Ventricular Tachyarrhythmias With Statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
38. Predictive Value of Ventricular Arrhythmia Inducibility for Subsequent Ventricular Tachycardia or Ventricular Fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Patients
39. Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator
40. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients
41. Analysis of mortality events in the multicenter automatic defibrillator implantation trial (MADIT-II)
42. Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction
43. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype
44. Location of mutation in the KCNQ1 gene does not influence outcome of long QT syndrome patients
45. Increased Risk of Arrhythmic Events in Long-QT Syndrome With Mutations in the Pore Region of the Human Ether-a-go-go–Related Gene Potassium Channel
46. Effectiveness and Limitations of β-Blocker Therapy in Congenital Long-QT Syndrome
47. Risk of cardiac events in family members of patients with long QT syndrome
48. Location of Mutation in the KCNQ1 and Phenotypic Presentation of Long QT Syndrome.
49. Modulation of microsomal glucose-6-phosphate translocase activity by free fatty acids: Implications for lipid domain structure in microsomal membranes.
50. Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome The Importance of the Maximum Corrected QT for Risk Stratification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.